Globus Medical is spine and reconstruction and one of the world's leading orthopedic suppliers.
Globus Medical has transformed from a focused spine company into a musculoskeletal solutions provider following its 2023 merger with NuVasive, creating a combined entity generating approximately $2.5 billion in annual revenue. The ExcelsiusGPS robotic and navigation platform — the leading robotic system in spine surgery with over 800 installations — and the newly launched ExcelsiusHIP for robotic-assisted hip arthroplasty represent the company's technology-anchored competitive differentiation strategy. The combined Globus-NuVasive entity is the most technology-active company in spine and is rapidly expanding its addressable market through musculoskeletal reconstruction.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Globus Medical — Key Financial Metrics 2023-2025
Table 2. Globus Medical — Revenue by Segment 2023-2025
Table 3. Globus Medical — Revenue by Geography 2023-2025
Table 4. Globus Medical — SWOT Analysis
Table 5. Globus Medical — Key Products and Platforms 2025
Table 6. Globus Medical — M&A Activity 2020-2025
Table 7. Globus Medical — Key Management 2025
Table 8. Globus Medical — Strategic Priorities 2025-2030
